Higuchi John W. 4
4 · Lipocine Inc. · Filed Jan 2, 2018
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Higuchi John W.
Director
Transactions
- Exercise/Conversion
Restricted stock units
2017-12-29−1,250→ 3,750 totalExercise: $0.00From: 2017-12-29Exp: 2027-01-25→ Common Stock (1.25 underlying) - Exercise/Conversion
Common Stock
2017-12-29+1,250→ 476,498 total
Footnotes (2)
- [F1]Represents shares of Lipocine Inc. common stock ("LPCN Common Stock") acquired upon the vesting of restricted stock units (see footnote 2).
- [F2]Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021.